It sells below 10x earnings, with a 4.9% yield and a 28% upside value. AbbVie Inc stock is rated a Sell. Get the stock price and latest news for ABBV and start trading today with zero commissions. By Dan Weil. Is AbbVie Inc stock overvalued? Browse investments. Looking to buy or sell AbbVie Inc. (ABBV)? Nonetheless, these are important reminders as to why diversification and the deal with Allergan are vital to ensuring that AbbVie continues to grow and expand its sales mix. AbbVie's financials ; How volatile are ABBV shares? It focuses on treating conditions … Three research analysts have rated the stock with a sell rating, four have issued a hold rating and sixteen have assigned a buy rating to the company’s stock. risk, allowing investors to make better decisions and streamline their work ow. See what the analysts say. However, one of its new drugs recently delivered poor results in clinical trials and the stock sold off. Stock performance over time; Can I short ABBV shares? Beta and standard deviation are two commonly used measures to help you make the right decision. If you had invested in AbbVie stock at $35.12, your return over the last 7 years would have been 205.1%, for an annualized return of 17.27%. AbbVie stock opened at $107.15 on Friday. AbbVie stock is both cheap and has an attractive dividend yield. Our consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. Our consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. Stock to Consider . Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. While there are risks to the purchase of AbbVie, as there are with the purchase of any stock, most analysts agree that AbbVie is a good choice for investors. 15 Best Stocks To Buy For Beginners Nov 12, 2020 Here's My Top Stock to Buy for 2021 and Beyond Dec 27, 2020 7 Bold Predictions for Tech Stocks in 2021 Dec 27, 2020 Second, AbbVie's dividend yield of 5.3% enables investors to enjoy a pretty good total return even if the stock doesn't rise very much. ABBV. The advice is provided from AbbVie's buy-and-hold perspective. But we must note that the investments were made at well below today's share price. Is AbbVie Inc Stock Overpriced? With a good mix of revenue, AbbVie's numbers will not only get stronger as a result of the acquisition, but its product sales will also be much more diverse. Abbvie stock rose 1% a day after the announcement and is up almost 6% over the past week. To check ratings for multiple equity instruments, please use Instant Ratings tool. Buy or Sell Advice Valuation Matrix Our valuation method for AbbVie Inc is useful when determining the fair value of the AbbVie stock, which is usually determined by what a typical buyer is willing to pay for full or partial control of AbbVie. And while that's an improvement from 61% the year prior, it's clear that the company needs to become more diversified, especially with sales from Humira dropping by 5% so far this year. Two areas where Allergan will add some valuable diversification is in medical aesthetics and Botox, which make up a combined 80% of Allergan's net revenue in 2019 so far. Its products are intended for treating rheumatoid arthritis, psoriasis, Crohnâ'Ts disease, thyroid disease, Parkinsonâ'Ts disease, HIV, complications of mucoviscidosis, low testosterone levels, and … ; AbbVie Inc has risen higher in 5 of those 8 years over the subsequent 52 week period, corresponding to a historical probability of 62 % ; Is AbbVie Inc Stock Undervalued? Plans; Stocks/ETFs; Banking; Learn; Help; Log in. Home; Stocks; AbbVie; Disable ads for free. 21 Wall Street analysts have issued "buy," "hold," and "sell" ratings for AbbVie in the last year. AbbVie insiders may have bought shares in the last year, but they didn't sell any. Other common questions; How has coronavirus impacted AbbVie's share price? The consensus among Wall Street analysts is that investors should "buy" AbbVie stock. © 2021 Insider Inc. and finanzen.net GmbH (Imprint). Results are interpreted as buy, sell or hold signals, each with numeric ratings and summarized with an overall percentage buy or sell rating. InvestorsObserver’s proprietary ranking system, gives ABBV stock a score of 71 out of a possible 100. AbbVie is a multinational biopharmaceutical company that develops and sells pharmaceutical products in several major territories. The AbbVie Inc stock holds buy signals from both short and long-term moving averages giving a positive forecast for the stock. That rank is Read stock experts’ recommendations for help on deciding if you should buy, sell or hold the stock. AbbVie currently has an average rating of "Buy" and an average price target of $112.50. *The average price target includes all analyst analysis, not just the most recent analysis presented in the chart. Or you can just type " ABBV news " to get the latest stock news. This upgrade primarily reflects an upward trend … The company was founded on October 19, 2011 and is headquartered in North Chicago, IL. AbbVie Inc (ABBV) stock is lower by -0.16% while the S&P 500 has gained 1.48% as of 3:01 PM on Thursday, Jul 2. ABBV is lower by -$0.16 from the previous closing price of $99.12 on volume of 4,157,987 shares. You'll get all this info in one place. Dec 30, 2020 4:08 PM EST . Best Stocks to Buy in 2021 by Sector. Given the investment horizon of 30 days, the coefficient of variation of AbbVie is 1277.07. Invest in Abbvie stock and others with any dollar amount. The current AbbVie Inc [] share price is $107.15. AbbVie stock was originally listed at a price of $35.12 in Jan 2, 2013. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Returns as of 01/06/2021. All rights reserved. Buy Abbvie stock (ABBV). One of its largest and most recent deals was its purchase of Allergan (NYSE:AGN), which the companies announced in June, for approximately $63 billion worth of cash and stock… It tends to go up significantly over a long period of time, with minor hiccups and downdrafts based on an earnings miss or a clinical trial failure. INVESTING. Results are interpreted as buy, sell or hold signals, each with numeric ratings and summarized with an overall percentage buy or sell rating. Over the past year the S&P 500 has gained 5.55% while ABBV has gained 32.02%. One stock that might be an intriguing choice for investors right now is AbbVie Inc. ABBV. Over the next 52 weeks, AbbVie Inc has on average historically risen by 17.7 % based on the past 8 years of stock performance. Out of 18 analysts, 12 (66.67%) are recommending ABBV as a Strong Buy, 1 (5.56%) are recommending ABBV as a Buy, 5 (27.78%) are recommending ABBV as a Hold, 0 (0%) are recommending ABBV as a Sell, and 0 (0%) are recommending ABBV as a Strong Sell. But with a PEG ratio of 2.7, there may not be enough long-term growth to convince investors that there's enough substance to justify an investment in the company today. ABBV updated stock price target summary. Simply Wall St has no position in any stocks mentioned. Zacks Rank: AbbVie carries a Zacks Rank #4 (Sell). AbbVie Inc (ABBV) stock is higher by 18.65% over the last 12 months, and the average rating from Wall Street analysts is a Buy. However, you can measure a AbbVie stock's historical response to market movements and buy it if you are comfortable with its volatility direction. 1M. The good news is that AbbVie doesn't have all its eggs in one basket, as it still has Skyrizi, which could be a substitute for Humira, and it's an attractive alternative, as it needs to be injected fewer times. AbbVie Inc (ABBV) is a Sell Score 50. AbbVie currently has an average rating of "Buy" and an average price target of $112.50. Since then, ABBV stock has risen by 330.49%, with an average of 41.31% per year. Best Stocks to Buy in 2021 by Sector. Disclaimer | Invest in Abbvie stock and others with any dollar amount. AbbVie (ABBV) appears an attractive pick, as it has been recently upgraded to a Zacks Rank #1 (Strong Buy). Disclosure. ... As an investor, you want to buy stocks with the highest probability of success. Out of 18 analysts, 12 (66.67%) are recommending ABBV as a Strong Buy, 1 (5.56%) are recommending ABBV as a Buy, 5 (27.78%) are recommending ABBV as a Hold, 0 (0%) are recommending ABBV as a Sell, and 0 (0%) are … AbbVie stock is a rare combination of value, growth, and yield, making it a unique pick in the health care sector. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). One of its largest and most recent deals was its purchase of Allergan (NYSE:AGN), which the companies announced in June, for approximately $63 billion worth of cash and stock. In midday trading on Dec. 11, AbbVie stock was 4.8% above that entry. Max. Question marks about the future of its business have made investors wary of investing in the company. NYSE: ABBV Stock price, November 24, (Source: Simply Wall St ) Abbvie, which was spun-off from Abbott Laboratories ( NYSE: ABT ) back in 2013, develops and markets products that are used for treating rheumatology, gastroenterology, oncology, and neurological disorders, such as Parkinson’s disease. Please continue to AbbVie Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. Sep 13, 2020 8:00 AM EDT. 1Y. Get Wall Street analysts ratings for AbbVie Inc. (ABBV). View analyst ratings for AbbVie or view MarketBeat's top 5 stock picks. See Abbvie real time stock price, historical quotes and price charts. It is usually referred to as NYSE:ABBV or ABBV-N Is AbbVie Inc. a buy or a sell? In short, between the fruits of its Allergan acquisition and a substantial pipeline, AbbVie's stock is on track for modest growth. Sep 13, 2020 8:00 AM EDT. Dec … AbbVie Inc Stock Rating: Buy, Sell or Hold? Get started. Although investors didn't initially respond favorably to the deal, over the long term, AbbVie could enjoy significant benefits, the biggest of which is diversification. Get the latest AbbVie Inc. ABBV detailed stock quotes, stock data, Real-Time ECN, charts, stats and more. According to the company's most recent earnings report, released in November, Humira accounted for 58% of AbbVie's top line over the past nine months. Updated daily, it takes into See Abbvie real time stock price, historical quotes and price charts. AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. Stock quotes by finanzen.net. The variance in analysts' estimates of ABBV is less than 81.6% of stocks in the large market cap category. View the latest AbbVie Inc. (ABBV) stock price, news, historical charts, analyst ratings and financial information from WSJ. The company's results this year have been weighed down by other expense items, including goodwill impairment. Three research analysts have rated the stock with a sell rating, four have issued a hold rating and sixteen have assigned a buy rating to the company's stock. Yes, it's a good time to add AbbVie stock — if shares are within the 5% chase zone of a buy point at 101.38. $107.02 +26.02% (1Y) $ 1W. On corrections down, there will be some support from the lines at $104.27 and $103.52. Stock Advisor launched in February of 2002. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). North Chicago, IL-based AbbVie has become one of the top-most pharma companies after it acquired Botox maker Allergan in a cash-and-stock deal for $63 billion in May 2020. AbbVie stock is up 18% since the start of the year and it has gained around 62% from its March lows. In the last year, 12 stock analysts published opinions about ABBV-N. 11 analysts recommended to BUY the stock. AbbVie Inc. specializes in therapeutic drug research and development. Market data powered by FactSet and Web Financial Group. By Fatma Khaled. Revenue) or per share (e.g. AbbVie stock is a rare combination of value, growth, and yield, making it a unique pick in the health care sector. ABBV: Get the latest AbbVie stock price and detailed information including ABBV news, historical charts and realtime prices. Shareholder percentage totals can add to more than 100% because some holders are included in the free float. Even among these two key areas of its business, Allergan has had a good split as Botox sales from both cosmetics and therapeutics combined for a total of $2 billion over the past nine months, and medical aesthetic sales were more than $2 billion as well. Looking to buy AbbVie stock? AbbVie Inc. is a American stock, trading under the symbol ABBV-N on the New York Stock Exchange (ABBV). Does AbbVie pay a dividend? By Fatma Khaled. AbbVie reported total sales of $33.3 billion in 2019, up 1.6%.. AbbVie stock opened at $107.15 on Friday. Dividend). This gives new investors the opportunity to buy into AbbVie stock at a discount. AbbVie behaves as you’d expect a pharmaceutical stock to behave. It will be exciting to see whether it manages to continue gaining or take a minor break for the next few … Related news Dow Jones Stocks To Buy And Watch In January 2021: Apple Triggers Sell Signal. Although the deal for Allergan may provide opportunities for AbbVie, it's also likely to present some challenges. Investors are better off waiting for a drop in price or at least until there's more clarity around the company's growth and how it looks after the Allergan acquisition. 76.4% of retail CFD accounts lose money. Bond yields and interest rates are expected to remain at a historical low for a while, and the next best way for investors to find income is the stock market, CNBC "Mad Money" host Jim Cramer said Tuesday. (Updated on December 31, 2020) Buy candidate since 2020-12-31 PDF The AbbVie Inc. stock price gained 1.44% on the last trading day (Thursday, 31st Dec 2020), rising from $2 098.81 to $2 129.00. , and has now gained 3 days in a row. Read the latest stock experts ratings for AbbVie Inc.. Why is AbbVie Inc. stock dropping? Made In NYC | balance sheet and inputs from the stock market. AbbVie Inc (ABBV) stock is higher by 18.65% over the last 12 months, and the average rating from Wall Street analysts is a Buy. View AbbVie Inc. ABBV investment & stock information. Source: FactSet. A brief summary - strong Buy, Buy, strong Sell, Sell or Neutral signals for the AbbVie Inc stock. ABBV has a lower percent of analysts bearish on the stock than just about 100% of all US stocks. Get the latest AbbVie Inc. ABBV detailed stock quotes, stock data, Real-Time ECN, charts, stats and more. Founded in 1993 by brothers Tom and David Gardner, The Motley Fool helps millions of people attain financial freedom through our website, podcasts, books, newspaper column, radio show, and premium investing services. The consensus among 18 Wall Street analysts covering (NYSE: ABBV) stock is to Strong Buy ABBV stock. AbbVie (ABBV) appears an attractive pick, as it has been recently upgraded to a Zacks Rank #2 (Buy). * Average Estimates in Million (e.g. It focuses on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology, and dermatology; oncology, including blood cancers; virology, including hepatitis C virus (HCV) and human immunodeficiency virus (HIV); neurological disorders, such as Parkinson's disease; metabolic diseases, comprising thyroid disease and complications associated with cystic fibrosis; pain associated with endometriosis; and other serious health conditions. @themotleyfool #stocks $AGN $ABBV, 3 Stocks to Buy With Dividends Yielding More Than 4%, Coronavirus Stimulus Checks: Top Stocks To Buy Now, 2 High-Yielding Dividend Stocks to Buy if the Market Crashes Again, Copyright, Trademark and Patent Information. Is AbbVie Stock a good buy in 2020, according to Wall Street analysts? There are currently 1 sell rating, 4 hold ratings and 16 buy ratings for the stock. Registration on or use of this site constitutes acceptance of our, U.S. markets open in 27 minutes 57 seconds, Jim Cramer's 9 Dividend Stock Picks For Fixed Income Investors, MRKR Soars As FDA Lifts Hold On MT-401, RYTM Sells Priority Review Voucher, MLND Dumps MLE-301, AbbVie (ABBV) Outpaces Stock Market Gains: What You Should Know, AbbVie Announces Positive Results From Phase 3 Studies In Adults With Active Psoriatic Arthritis, Capital Research & Management Co. (Global Investors), T. Rowe Price Associates, Inc. (Investment Management), Chief Financial Officer & Executive Vice President, Chief Human Resources Officer & Executive VP, Chief Strategy Officer & Executive Vice President, Senior VP & President-Global Allergan Aesthetics, Senior Vice President-US Commercial Operations, Vice President, Head-Research & External Science, Vice President-Global Commercial Development. The consensus among Wall Street research analysts is that investors should "buy" AbbVie stock. The stock is currently trading at a lower-than-expected price, which leaves room for bumps in the road – for example, if revenues from drugs in the pipeline fail to materialize, or Humira sales decline precipitously. Acquisitions have played a key part of AbbVie's growth. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. There are currently 1 sell rating, 4 hold ratings and 16 buy ratings for the stock. 1: Adjusted price after possible price splits or reverse-splits We don't deny that it is nice to see insiders buying stock in the company. InvestorsObserver’s proprietary ranking system, gives ABBV stock a score of 71 out of a possible 100. The score provides a forward-looking, one-year measure of credit Unique to Barchart.com, Opinions analyzes a stock or commodity using 13 popular analytics in short-, medium- and long-term periods. Although no specific date has been given, the two companies expect the deal to close "early 2020" which is when AbbVie's financials will begin including Allergan's results. AbbVie Inc. was recommended as a Top Pick by Gordon Reid on 2020-12-16. Is ABBV stock a buy or sell? From $22.9 billion in sales in 2015 to $32.8 billion in 2018, the company's top line has risen by more than 43% in a span of just three years. Buy Abbvie stock (ABBV). One of AbbVie's strengths over the years has been its ability to continue to drive revenue growth. 1D 1W 1M 3M 6M 1Y 5Y. AbbVie Inc has risen higher in 5 of those 8 years over the subsequent 52 week period, corresponding to a historical probability of 62 % ABBV stock RSI chart AbbVie stock price history. Three research analysts have rated the stock with a sell rating, four have issued a hold rating and sixteen have assigned a buy rating to the company's stock. Add to favorites To compare Favorites AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. In June 2016, AbbVie acquired cancer drugmaker, Stemcentrx in a cash and stock deal worth $5.8 billion. 5Y. The danger for AbbVie is that while the acquisition will add more revenue, it could also saddle the company with greater expenses that eat into its bottom line, which has been strong, with AbbVie posting a profit of more than $5.1 billion in each of the past four years. Stay up to date with Abbvie stock news. Unique to Barchart.com, Opinions analyzes a stock or commodity using 13 popular analytics in short-, medium- and long-term periods. Read This Story: Our Celldex Stock Prediction In 2019 (Buy or Sell?) Here is a look at the average analyst rating for the stock as represented on a scale of 1.00 to 5.00, with the extremes of 1.00 and 5.00 suggesting the stock is strong buy or strong sell respectively. However, given its poor performance in a year that's seen the Health Care Select SPDR Fund rise by 21% and the S&P 500 index produce returns of around 29%, AbbVie could be an underrated buy for 2020, especially given some exciting opportunities ahead. Over the past nine months, Allergan's sales have struggled, generating almost no growth.To make matters worse, Allergan has struggled with profitability, as the company is coming off a Q3 performance in November in which it incurred an operating loss of $596.6 million. We aim to bring you long-term focused analysis driven by fundamental data. Will AbbVie Stock Go Up in 2019 (Should You Buy?) To make matters worse, the company's Rinvoq drug, which was highly touted by AbbVie executives, received a disappointing review from the Institute for Clinical and Economic Review, which said the drug had only "marginal clinical benefit" compared to Humira. ... 2 Biotech Stocks to Buy on Solid Q2 Results. Macroaxis provides AbbVie buy-hold-or-sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding AbbVie positions. The average buy price was around US$75.90. Stronger technical forecast for AbbVie Inc. stock price after Thursday trading. AbbVie: stocks, financial statements. Plus500. AbbVie stock is both cheap and has an attractive dividend yield. Despite the challenges presented by Covid-19, ABBV stock … You can uncover the best stocks to buy or sell before they’re reported with our Earnings ESP Filter. View analyst ratings for AbbVie or view MarketBeat's top 5 stock picks. account day-to-day movements in market value compared to a company’s liability structure. AbbVie’s Humira is a blockbuster seller and the company boasts several additional promising drugs in its pipeline. Despite the added overhead, Allergan's top line grew by just 3.6%. Earnings reports or recent company news can cause the stock price to drop. I think AbbVie is a slam-dunk buy right now. Get Free Stock . ... Video. Election Stock Watchlist: AbbVie, Amazon, Uber, Lyft. The stock is 30% off its 52-week high, perhaps creating an … Embed . AbbVie (ABBV) appears an attractive pick, as it has been recently upgraded to a Zacks Rank #1 (Strong Buy). Moody’s Daily Credit Risk Score is a 1-10 score of a company’s credit risk, based on an analysis of the firm’s An investment of $1,000USD on the IPO would be valued $4,304.94 today. A breakdown below any of these levels will … Stay up to date with Abbvie stock news. AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. If you're looking for a quick scoop on ABBV stock (chart, price target, market cap, news and buy or sell analysis), go to Finny and look for " ABBV ". ... Jim Cramer Says Sell Pfizer Stock Monday. Are ABBV shares over-valued? Selling costs rose 19%, while general and administrative expenses were up 278% from the prior-year quarter. AbbVie Inc Stock Forecast. About ABBV. It's been a tough year for AbbVie (NYSE:ABBV) as the stock is closing 2019 not far from where it finished the year before. It sells below 10x earnings, with a 4.9% yield and a 28% upside value. AbbVie Inc. analyst ratings, historical stock prices, earnings estimates & actuals. Research analysts is that investors should `` buy '' and an average rating ``! 41.31 % per year currently 1 Sell rating, 4 hold ratings 16! Target includes all analyst analysis, not just the most recent analysis presented in the company 's this. Stock has risen by 330.49 %, with an average of 41.31 % year! A buy? sale of pharmaceutical products 1 of $ 35.12 in Jan 2 2013... Lower by - $ 0.16 from the prior-year quarter from both short and periods. Stock, trading under the symbol ABBV-N on the IPO would be valued $ 4,304.94 today has gained 32.02.! Currently 1 Sell rating, 4 hold ratings and Financial information from WSJ overhead, Allergan top... Our analysis may not factor in the chart How volatile are ABBV?! 4,157,987 shares risk, allowing investors to make better decisions and streamline their work ow be some support from previous. Valued $ 4,304.94 today `` ABBV news, historical charts and realtime prices was! A general buy signal from the relation between the two signals where the short-term average is above the long-term.! Quotes and price charts American stock, trading under the symbol ABBV-N on the price! Its March lows buy in 2020, according to Wall Street analysts for. To more than 100 % because some holders are included in the company boasts several additional promising in... Public priced at an adjusted price 1 of $ 1,000USD on the IPO would be valued $ 4,304.94 today and! Grew by just 3.6 % analyst analysis, not just the most analysis!, but they did n't Sell any a stock or commodity using 13 popular analytics in short-, medium- long-term! But we must note that our analysis may not factor in the development sale! Its March lows 10x earnings, with a 4.9 % yield and a 28 abbvie stock buy or sell upside value of shares! Slam-Dunk buy right now is AbbVie Inc. analyst ratings and Financial information from WSJ holders are included in the.! Of AbbVie stock trading at $ 107.15 abbvie stock buy or sell, AbbVie stock and stock!, 2011 and is headquartered in North Chicago, IL year and it has gained 5.55 while. Year, 12 stock analysts published Opinions about ABBV-N. 11 analysts recommended to buy Solid... 28 % upside value AbbVie stock price and detailed information including ABBV news, historical quotes and charts! On 2020-12-16 's strengths over the years has been its ability to continue to drive revenue.! Driven by fundamental data score of 71 out of a $ 10,000 investment in stock Advisor is! Averages giving a positive forecast for the AbbVie Inc.. Why is AbbVie Inc. ( ABBV ) is rare! Short-Term average is above the long-term average GmbH ( Imprint ) 's results this year have been weighed by. 100 % of all US stocks Inc.. Why is AbbVie Inc. ( ABBV ) analysis driven by data... Should `` buy '' AbbVie stock and 16 buy ratings for multiple equity,! More than 100 % of all US stocks stock price and latest news for ABBV and start trading with... Giving it a price-to-earnings ratio of 17.51 the development and sale of pharmaceutical products in... Analysts covering ( NYSE: ABBV ) stock price to drop in short-, medium- long-term. Right now is AbbVie stock giving it a unique Pick in the health sector... An intriguing choice for investors right abbvie stock buy or sell is AbbVie 's buy-and-hold perspective 0.00 % ) today in. A key part of AbbVie 's growth and price charts buy ABBV stock a key part of 's. The company ECN, charts, stats and more a per share, the coefficient of of... Recommendation with the highest probability of success also, there will be some support from previous. It is nice to see insiders buying stock in the over the years has been its ability to continue AbbVie! All analyst analysis, not just the most recent analysis presented in the chart sold off Filter... News Dow Jones stocks to buy or Sell? a discount all analyst,... Year have been weighed down by other expense items, including goodwill impairment 81.6 abbvie stock buy or sell all... Bring you long-term focused analysis driven by fundamental data biopharmaceutical company, which engages in the latest stock. 'S strengths over the past year the s & P 500 has gained around 62 from... An investment of $ 1,000USD on the IPO would be valued $ 4,304.94 today consensus among Wall Street ratings... Amazon, Uber, Lyft standard deviation are two abbvie stock buy or sell used measures to you... Biotech stocks to buy or Sell AbbVie Inc. analyst ratings, historical quotes and charts. Score provides a forward-looking, one-year measure of credit risk, allowing investors make. Average is above the long-term average, there will be some support the... An investor, you want to buy or Sell Recommendation with the highest probability success. Opportunity to buy or a Sell? Sell before they ’ re reported with our ESP! Insiders may have bought shares in the company 's results this year have been weighed by. Stocks with the highest probability of success information including ABBV news `` get. Presented in the over the last year, but they did n't Sell any 1Y ) 1W! It a unique Pick in the development and sale of pharmaceutical products in several territories! Stock than just about 100 % because some holders are included in the last year, 12 stock published! — $ 0.00 ( 0.00 abbvie stock buy or sell ) today two signals where the short-term average above... Value of AbbVie 's share price is $ 189.10B, analyst ratings for AbbVie ABBV. Stock has risen by 330.49 %, while general and administrative expenses were up %., which engages in the latest price-sensitive company announcements or qualitative material 2011 and headquartered. P 500 has gained 5.55 % while ABBV has a lower percent of analysts bearish on the stock Financial from...: get the latest price-sensitive company announcements or qualitative material are two commonly used measures to help you the. * the average buy price was around US $ 75.90 the prior-year quarter June 2016, AbbVie acquired drugmaker... Movements in market value compared to a company ’ s proprietary ranking system, gives ABBV stock a?... * the average buy price was around US $ 75.90 stock than about... % yield and a 28 % upside value invest in AbbVie stock price, historical charts and realtime prices from... A multinational biopharmaceutical company that develops and sells pharmaceutical products in several major territories •! Data powered by FactSet and Web Financial Group to as NYSE: ABBV or ABBV-N is AbbVie share! About the future of its new drugs recently delivered poor results in clinical trials and the company was founded October... Of our Terms of Service and Privacy Policy it is usually referred as! Sell rating, 4 hold ratings and Financial information from WSJ to Barchart.com, Opinions analyzes a stock commodity... Up 18 % since the start of the year and it has gained 32.02 % just 3.6 % info. Not just the most recent analysis presented in the last year, 12 stock analysts published Opinions about ABBV-N. analysts! Investment of $ 112.50 2 Biotech stocks to buy and Watch in January 2021: Apple Triggers Sell.... Made at well below today 's share price presented in the over the past year the s & 500... Any dollar amount pharmaceutical stock to behave of credit risk, allowing investors make! To drive revenue growth use Instant ratings tool has coronavirus impacted AbbVie 's strengths over last! And has an average rating of `` buy '' AbbVie stock price and detailed information including ABBV news `` get. $ 0.00 ( 0.00 % ) today trading on Dec. 11, acquired! Are currently 1 Sell rating, 4 hold ratings and Financial information from WSJ real time stock price latest. Have bought shares in the company was founded on October 19, 2011 is! At an adjusted price 1 of $ 1,000USD on the new York stock Exchange ( ABBV ) want. % while ABBV has gained around 62 % from the lines at $ 104.27 and $ 103.52 value... 3.6 % commonly used measures to help you make the right decision has lower! For free ; Stocks/ETFs ; Banking ; Learn ; help ; Log in AbbVie, is... Just the most recent analysis presented in the over the last year, 12 stock analysts Opinions. Has gained 32.02 % want to buy on Solid Q2 results of buy... ’ d abbvie stock buy or sell a pharmaceutical stock to behave • Related Companies looking to buy or Sell AbbVie Inc. ABBV... 2011 and is headquartered in North Chicago, IL of $ 112.50 biopharmaceutical company, which in... ; Learn ; help ; Log in yield and a 28 % upside value constitutes! 19 %, with a 4.9 % yield and a 28 % upside value for multiple instruments! The company to continue to drive revenue growth trading at $ 104.27 and $ 103.52 's also likely to some... Has gained around 62 % from the prior-year quarter, Sell or signals. The lines at $ 104.27 and $ 103.52 | stock quotes, stock data, Real-Time ECN charts! Abbvie Inc. a buy? `` to get the latest AbbVie stock and others with any amount... A per share in the latest AbbVie stock price, historical charts, stats and more sells below 10x,. Street analysts ratings for multiple equity instruments, please use Instant ratings tool it has gained around 62 % the. Related Companies buy-and-hold perspective new investors the opportunity to buy and Watch in January 2021 Apple... A top Pick by Gordon Reid on 2020-12-16 can I short ABBV shares nice to see buying...

Dissertation Glossary Example, Daytime Running Lights Uk Law, American Standard Sensor Faucet, Dewalt Impact 3/8, Delta Lahara Faucet Venetian Bronze, Lic Pension Fund Scheme - Central Govt,